In trading on Monday, shares of Ingram Micro Inc. (IM) crossed below their last reported book value — defined as common shareholder equity per share — of $24.79, changing hands as low as $23.51 per share. Ingram Micro Inc. shares are currently trading off about 6% on the day. The chart below shows the one year performance of IM shares, versus its 50 and 200 day moving averages:Looking at the chart above, IM's low point in its 52 week range is $16.96 per share, with $26.12 as the 52 week high point — that compares with a last trade of $23.51. According to the ETF Finder at ETF Channel, IM makes up 2.07% of the First Trust Technology AlphaDEX Fund ETF ( FXL) which is trading lower by about 2.7% on the day Monday.
More from Stocks
Hasbro Stock Drop Following Acquisition Is Overdone, DA Davidson Suggests
Analyst Linda Bolton Weiser called Hasbro's deal for Entertainment One EPS accretive and a strategic match.
La-Z-Boy Gets Moving After Analyst Upgrade of Furniture Maker
While noting the combination of China tariffs and recession fears may 'frighten some to the sidelines,' analysts at Raymond James cite the furniture maker's strong balance sheet with 'no funded debt,' rising dividends since 2013, and a still 'healthy U.S. consumer.'
Stocks Fall as Fed Chairman Vows to Continue Expansion but China Tariffs Bite
Stocks are falling Friday despite Federal Reserve Chairman Jerome Powell pledging to sustain the U.S. economic expansion as sentiment is dented by China saying it would take retaliatory measures in its tariff battle with the U.S.
Salesforce's Earnings and Guidance Aren't Quite as Impressive as They Look
Salesforce's Q2 performance was strong but its acquisitions muddy the year-over-year comparisons. Plus, its valuation gives its shares little margin for safety.
A Pair of Rare Disease Biotech Concerns Worth a Good Look
Alexion Pharmaceuticals is a solid company that is the subject of acquisition rumors and Amicus Therapeutics has a key drug off to a strong start.